The integrity of filter membranes is critical for maintaining sterile filtration.

Filter Integrity Testing 

Will traditional testing methods work for new therapeutic modalities?

Sufficiently specific and sensitive?

Common analysis approaches may be robust but still have limitations.

Beyond Elemental Impurity Analysis

Development timelines must accommodate all crucial elements of toxicology studies.

Ensuring Drugs are Safe

Topic

Articles

The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.

Roche and Cambridge Quantum Computing Use Algorithms for Early Alzheimer's Drug Research

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

SPT Labtech Strengthens Automation Services with BioMicroLab Acquisition

The new ultra-sensitive second-generation micro-chip technology is a key enabler in advanced single-cell proteomics workflow.

PharmaFluidics Offers Second-Gen µPAC Technology for Single Cell Proteomics

PathoQuest will apply its experience in viral safety testing and quality control of biologics for mitigating the risk of adventitious agent contamination in biopharmaceutical manufacturing.

PathoQuest Joins CAACB Consortium as Viral Safety Expert

This article provides an overview of the key risks that can be associated with the use of secondary reference standards (RS) and illustrates scientific challenges associated with transitioning from pharmacopeial RS to secondary RS. 

The Value of Pharmacopeial Reference Standards

Emily Johnston is a senior analytics engineer with Seeq.

Sharing process insights across the stages of drug development improves tech transfer.

Optimizing Tech Transfer with Advanced Analytics 

Editor of Pharmaceutical Technology Europe

Common approaches to analyze elemental impurities for compliance with regulatory requirements are robust but still have some limitations.

Approaching Elemental Impurity Analysis

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Having a clear and detailed understanding of exactly what a biomolecule entails is essential for therapeutics development.

Protein Characterization Can Support Regulatory Submission

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

Nexelis Expands Bioanalytical Services with Bioanalytical Lab Acquisition

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.